David S. Riley’s interest in the history, methodology and results of homeopathic drug provings began with his exposure to homeopathy in 1988 and his later study at the Hahnemann College of Homeopathy in Albany, California. The homeopathic drug provings published here are the result of his investigation of the research methods associated with homeopathic drug provings and contemporary research methodology. Dr. Riley has developed explicit and transparent research tools for (1) symptom selection criteria, (2) electronic data collection, and (3) blinding to reduce bias. These homeopathic drugs provings follow good clinical practice research guidelines (GCP) and incorporate the guidelines suggested by Dr. Samuel Hahnemann more than 200 years ago

Interrelated histories of colonial medicine, market and family reveal how Western homeopathy was translated and made vernacular in colonial India.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.